Clinics in Dermatology
Volume 24, Issue 4 , Pages 317-325 , July 2006

Comparative dermatology—canine endocrine dermatoses

References 

  1. Feldman EC, Nelson RW. In: Canine and feline endocrinology and reproduction. 3rd ed.. St. Louis (MO): W.B. Saunders; 2004;p. 86–151
  2. Muller GH, Kirk RW, Scott DW, et al. In: Muller and Kirk's small animal dermatology. 6th ed.. Philadelphia: W.B. Saunders; 2001;p. 780–885
  3. Scott-Moncrieff JC, Azcona-Olivera J, Glickman NW, et al. Evaluation of antithyroglobulin antibodies after routine vaccination in pet and research dogs. J Am Vet Med Assoc. 2002;221:515–521
  4. Breyer U, Reese S, Deeg C, et al. Diagnostische und pradiktive Wertigkeit von thyreoglobulinspezifischen Autoantikorpern (TgAAk) beim Hund. Tierarztl Prax. 2004;32:207–213
  5. Greco DS, Feldman EC, Peterson ME, et al. Congenital hypothyroid dwarfism in a family of giant schnauzers. J Vet Intern Med. 1991;5:57–65
  6. Mooney CT, Anderson TJ. Congenital hypothyroidism in a boxer dog. J Small Anim Pract. 1993;34:31–35
  7. Torres SM, McKeever PJ, Johnston SD. Effect of oral administration of prednisolone on thyroid function in dogs. Am J Vet Res. 1991;52:416–421
  8. Kaptein EM, Moore GE, Ferguson DC, et al. Effects of prednisone on thyroxine and 3,5,3′-triiodothyronine metabolism in normal dogs. Endocrinology. 1992;130:1669–1679
  9. Ferguson DC, Peterson ME. Serum free and total iodothyronine concentrations in dogs with hyperadrenocorticism. Am J Vet Res. 1992;53:1636–1640
  10. Panciera DL. Hypothyroidism in dogs: 66 cases (1987-1992). J Am Vet Med Assoc. 1994;204:761–767
  11. Panciera DL. An echocardiographic and electrocardiographic study of cardiovascular function in hypothyroid dogs. J Am Vet Med Assoc. 1994;205:996–1000
  12. Bichsel P, Jacobs G, Oliver JE. Neurologic manifestations associated with hypothyroidism in four dogs. J Am Vet Med Assoc. 1988;192:1745–1747
  13. Jaggy A, Oliver JE, Ferguson DC, et al. Neurological manifestations of hypothyroidism: a retrospective study of 29 dogs. J Vet Intern Med. 1994;8:328–336
  14. Indrieri RJ, Whalen LR, Cardinet GH, et al. Neuromuscular abnormalities associated with hypothyroidism and lymphocytic thyroiditis in three dogs. J Am Vet Med Assoc. 1987;190:544–548
  15. Budsberg SC, Moore GE, Klappenbach K. Thyroxine-responsive unilateral forelimb lameness and generalized neuromuscular disease in four hypothyroid dogs. J Am Vet Med Assoc. 1993;202:1859–1860
  16. Fatjo J, Stub C, Manteca X. Four cases of aggression and hypothyroidism in dogs. Vet Rec. 2002;151:547–548
  17. Henik RA, Dixon RM, Intravenous administration of levothyroxine for treatment of suspected myxedema coma complicated by severe hypothermia in a dog. J Am Vet Med Assoc 2000;216:713-717, 685.
  18. Credille KM, Slater MR, Moriello KA, et al. The effects of thyroid hormones on the skin of beagle dogs. J Vet Intern Med. 2001;15:539–546
  19. Daminet S, Ferguson DC. Influence of drugs on thyroid function in dogs. J Vet Intern Med. 2003;17:463–472
  20. Frank LA, Hnilica KA, May ER, et al. Effects of sulfamethoxazole-trimethoprim on thyroid function in dogs. Am J Vet Res. 2005;66:256–259
  21. Torres SM, Feeney DA, Lekcharoensuk C, et al. Comparison of colloid, thyroid follicular epithelium, and thyroid hormone concentrations in healthy and severely sick dogs. J Am Vet Med Assoc. 2003;222:1079–1085
  22. Yilmaz Z, Golcu E, Yalcin E, et al. T3, T4 and TSH concentrations in dogs with non-thyroidal illness. Indian Vet J. 2003;80:49–51
  23. Peterson ME, Melian C, Nichols R. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs. J Am Vet Med Assoc. 1997;211:1396–1402
  24. Scott-Moncrieff JC, Nelson RW, Bruner JM, et al. Comparison of serum concentrations of thyroid-stimulating hormone in healthy dogs, hypothyroid dogs, and euthyroid dogs with concurrent disease. J Am Vet Med Assoc. 1998;212:387–391
  25. Dixon RM, Mooney CT. Evaluation of serum free thyroxine and thyrotropin concentrations in the diagnosis of canine hypothyroidism. J Small Anim Pract. 1999;40:72–78
  26. Schachter S, Nelson RW, Scott-Moncrieff C, et al. Comparison of serum-free thyroxine concentrations determined by standard equilibrium dialysis, modified equilibrium dialysis, and 5 radioimmunoassays in dogs. J Vet Intern Med. 2004;18:259–264
  27. Dixon RM, Graham PA, Mooney CT. Serum thyrotropin concentrations: a new diagnostic test for canine hypothyroidism. Vet Rec. 1996;138:594–595
  28. Dixon RM, Reid SW, Mooney CT. Treatment and therapeutic monitoring of canine hypothyroidism. J Small Anim Pract. 2002;43:334–340
  29. Scott-Moncrieff JC, Nelson RW. Change in serum thyroid-stimulating hormone concentration in response to administration of thyrotropin-releasing hormone to healthy dogs, hypothyroid dogs, and euthyroid dogs with concurrent disease. J Am Vet Med Assoc. 1998;213:1435–1438
  30. Frank LA. Comparison of thyrotropin-releasing hormone (TRH) to thyrotropin (TSH) stimulation for evaluating thyroid function in dogs. J Am Anim Hosp Assoc. 1996;32:481–487
  31. Patzl M, Mostl E. Determination of autoantibodies to thyroglobulin, thyroxine and triiodothyronine in canine serum. J Vet Med A Physiol Pathol Clin Med. 2003;50:72–78
  32. Tani H, Shimizu R, Sasai K, et al. Recognition pattern of thyroglobulin autoantibody from hypothyroid dogs to tryptic peptides of canine thyroglobulin. J Vet Med Sci. 2003;65:1049–1056
  33. Lee JY, Uzuka Y, Tanabe S, et al. Prevalence of thyroglobulin autoantibodies detected by enzyme-linked immunosorbent assay of canine serum in hypothyroid, obese and healthy dogs in Japan. Res Vet Sci. 2004;76:129–132
  34. Dixon RM, Mooney CT. Canine serum thyroglobulin autoantibodies in health, hypothyroidism and non-thyroidal illness. Res Vet Sci. 1999;66:243–246
  35. Kemppainen RJ, Young DW, Behrend EN, et al. Autoantibodies to triiodothyronine and thyroxine in a golden retriever. J Am Anim Hosp Assoc. 1996;32:195–198
  36. Nachreiner RF, Refsal KR, Graham PA, et al. Prevalence of serum thyroid hormone autoantibodies in dogs with clinical signs of hypothyroidism. J Am Vet Med Assoc. 2002;220:466–471
  37. Nachreiner RF, Refsal KR, Ravis WR, et al. Pharmacokinetics of l-thyroxine after its oral administration in dogs. Am J Vet Res. 1993;54:2091–2098
  38. Kaptein EM, Moore GE, Ferguson DC, et al. Thyroxine and triiodothyronine distribution and metabolism in thyroxine-replaced athyreotic dogs and normal humans. Am J Physiol. 1993;264:E90–E100
  39. Greco DS, Peterson ME, Davidson AP, et al. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995). J Am Vet Med Assoc. 1999;214:1349–1353
  40. Ford SL, Feldman EC, Nelson RW. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988). J Am Vet Med Assoc. 1993;202:789–792
  41. Feldman EC, Nelson RW. In: Canine and feline endocrinology and reproduction. 3rd ed.. St. Louis (MO): W.B. Saunders; 2004;p. 252–357
  42. Nichols R. Concurrent illness and complications associated with canine hyperadrenocorticism. Semin Vet Med Surg (Small Anim). 1994;9:132–136
  43. LaRue MJ, Murtaugh RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc. 1990;97:1368–1372
  44. Ortega TM, Feldman EC, Nelson RW, et al. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J Am Vet Med Assoc. 1996;209:1724–1729
  45. Hess RS, Kass PH, Ward CR. Association between hyperadrenocorticism and development of calcium-containing uroliths in dogs with urolithiasis. J Am Vet Med Assoc. 1998;212:1889–1891
  46. Blaxter AC, Gruffydd-Jones TJ. Concurrent diabetes mellitus and hyperadrenocorticism in the dog: diagnosis and management of eight cases. J Small Anim Pract. 1990;31:117–122
  47. Stewart LJ. The integumentary changes of hyperadrenocorticism. Semin Vet Med Surg (Small Anim). 1994;9:123–126
  48. Mack RE, Feldman EC, Wilson SM. Diagnosis of hyperadrenocorticism in dogs. Compend Small Anim Pract. 1994;16:311–329
  49. Frank LA, DeNovo RC, Kraje AC, et al. Cortisol concentrations following stimulation of healthy and adrenopathic dogs with two doses of tetracosactrin. J Small Anim Pract. 2000;41:308–311
  50. Van Liew CH, Greco DS, Salman MD. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995). J Am Vet Med Assoc. 1997;211:322–325
  51. May ER, Frank LA, Hnilica KA, et al. Effects of a mock ultrasonographic procedure on cortisol concentrations during low-dose dexamethasone suppression testing in clinically normal adult dogs. Am J Vet Res. 2004;65:267–270
  52. Rijnberk A, van Wees A, Mol JA. Assessment of two tests for the diagnosis of canine hyperadrenocorticism. Vet Rec. 1988;122:178–180
  53. Ristic JME, Ramsey IK, Heath FM, et al. The use of 17-hydroxyprogesterone in the diagnosis of canine hyperadrenocorticism. J Vet Intern Med. 2002;16:433–439
  54. Norman EJ, Thompson H, Mooney CT. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia. Vet Rec. 1999;144:551–554
  55. Hill KE, Scott-Moncrieff JC, Koshko MA, et al. Secretion of sex hormones in dogs with adrenal dysfunction. J Am Vet Med Assoc. 2005;226:556–561
  56. Reusch CE, Feldman EC. Canine hyperadrenocorticism due to adrenocortical neoplasia. J Vet Intern Med. 1991;5:3–10
  57. Plotnick A. Diagnosing canine hyperadrenocorticism: keeping things simple. Vet Forum. 2004;34–41
  58. Peterson ME, Kintzer PP. Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane. Vet Clin North Am Small Anim Pract. 1997;27:255–272
  59. den Hertog E, Braakman JC, Teske E, et al. Results of non-selective adrenocorticolysis by o,p'-DDD in 129 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec. 1999;144:12–17
  60. Sennello KA, Panciera DL, Lanz OI, et al. Treating adrenal neoplasia in dogs and cats. Vet Med. 2004;172–186
  61. Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res. 2002;63:506–512
  62. Braddock JA, Church DB, Robertson ID, et al. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Aust Vet J. 2003;81:600–607
  63. Chapman PS, Kelly DF, Archer J, et al. Adrenal necrosis in a dog receiving trilostane for the treatment of hyperadrenocorticism. J Small Anim Pract. 2004;45:307–310
  64. Reusch CE, Steffen T, Hoerauf A. The efficacy of l-deprenyl in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med. 1999;13:291–301
  65. Braddock JA, Church DB, Robertson ID, et al. Inefficacy of selegiline in treatment of canine pituitary-dependent hyperadrenocorticism. Aust Vet J. 2004;82:272–277
  66. Melby JC. Therapy of Cushing disease: a consensus for pituitary microsurgery. Ann Intern Med. 1988;109:445–446
  67. Axlund TW, Behrend EN, Winkler JT. Surgical treatment of canine hyperadrenocorticism. Compend Small Anim/Exot. 2003;25:334–347
  68. Anderson CR, Birchard SJ, Powers BE, et al. Surgical treatment of adrenocortical tumors: 21 cases (1990-1996). J Am Anim Hosp Assoc. 2001;37:93–97
  69. Suess RP, Barr SC, Sacre BJ, et al. Bone marrow hypoplasia in a feminized dog with an interstitial cell tumor. J Am Vet Med Assoc. 1992;200:1346–1348
  70. Barsanti JA, Medleau L, Latimer K. Diethylstilbestrol-induced alopecia in a dog. J Am Vet Med Assoc. 1983;182:63–64
  71. Peters MA, de Jong FH, Teerds KJ, et al. Ageing, testicular tumours and the pituitary-testis axis in dogs. J Endocrinol. 2000;166:153–161
  72. Medleau L. Sex hormone–associated endocrine alopecias in dogs. J Am Anim Hosp Assoc. 1989;25:689–694
  73. Nemzek JA, Homco LD, Wheaton LG, et al. Cystic ovaries and hyperestrogenism in a canine female pseudohermaphrodite. J Am Anim Hosp Assoc. 1992;28:402–406
  74. Rosychuk RAW. Cutaneous manifestations of endocrine disease in dogs. Compend Small Anim Pract. 1998;20:287–302
  75. Frank LA. Sex hormone dermatoses. Small Anim Dermatol Secrets. 2004;280–288
  76. Syme HM, Scott-Moncrieff JC, Treadwell NG, et al. Hyperadrenocorticism associated with excessive sex hormone production by an adrenocortical tumor in two dogs. J Am Vet Med Assoc 2001;219:1725-8, 1707-8.

PII: S0738-081X(06)00048-4

doi: 10.1016/j.clindermatol.2006.04.007

Clinics in Dermatology
Volume 24, Issue 4 , Pages 317-325 , July 2006

Article Tools

* Image Usage & Resolution